| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.01 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.01 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.18 | 0.01 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.01 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.073 | 0.02 |